Inna Dobreva* and Petko Karagyozov Pages 1 - 4 ( 4 )
The liver represents the major site of drug metabolism, i.e. the key organ in the processes of detoxification and elimination of drugs from the organism. It is therefore often affected by toxic metabolites and suffers sometimes fatal consequences. The spectrum of pathologies differs by the cell type primarily damaged and the group of the cholangiopathies includes those conditions affecting the bile duct epithelium or the cholangiocytes. They can range from transient cholestasis to vanishing bile duct syndrome and sclerosing cholangitis, both leading eventually to the development of biliary fibrosis and cirrhosis. In this review article we focus on the etiology, predisposing factors, clinical manifestations and histopathological characteristics of bile duct injury as a consequence of drug treatment and discuss separately the different bile duct pathologies.
Drug-induced cholangiopathy, drug-induced vanishing bile duct syndrome (VBDS), drug-induced ductopenia, disappearing intrahepatic bile ducts.
Interventional Gastroenterology, Acibadem City Clinic Tokuda Hospital, Sofia, Interventional Gastroenterology, Acibadem City Clinic Tokuda Hospital, Sofia